| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McManus Matthew | President - Diag & Spatial Bio | 614 MCKINLEY PLACE NE, MINNEAPOLIS | /s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed. | 19 Aug 2025 | 0001908268 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Common Stock | Options Exercise | $0 | +2.64K | +88.55% | $0.00 | 5.62K | 15 Aug 2025 | Direct | |
| transaction | TECH | Common Stock | Tax liability | -$47.2K | -880 | -15.67% | $53.60 | 4.74K | 15 Aug 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Restricted Stock Units | Options Exercise | $0 | -2.64K | -33.33% | $0.00 | 5.28K | 15 Aug 2025 | Common Stock | 2.64K | Direct | F1, F6 | |
| transaction | TECH | Performance Restricted Stock Units | Award | $0 | +19.2K | $0.00 | 19.2K | 15 Aug 2025 | Common Stock | 19.2K | Direct | F1, F8 | ||
| transaction | TECH | Restricted Stock Units | Award | $0 | +9.62K | $0.00 | 9.62K | 15 Aug 2025 | Common Stock | 9.62K | Direct | F1, F9 | ||
| transaction | TECH | Stock Option (Right to Buy) | Award | $0 | +24.6K | $0.00 | 24.6K | 15 Aug 2025 | Common Stock | 24.6K | $53.60 | Direct | F10 | |
| holding | TECH | Performance Restricted Stock Units | 2.89K | 15 Aug 2025 | Common Stock | 2.89K | Direct | F1, F2 | ||||||
| holding | TECH | Performance Stock Option (Right to Buy) | 7.95K | 15 Aug 2025 | Common Stock | 7.95K | $68.54 | Direct | F2 | |||||
| holding | TECH | Restricted Stock Units | 9.24K | 15 Aug 2025 | Common Stock | 9.24K | Direct | F1, F3 | ||||||
| holding | TECH | Stock Option (Right to Buy) | 15.9K | 15 Aug 2025 | Common Stock | 15.9K | $68.54 | Direct | F4 | |||||
| holding | TECH | Performance Restricted Stock Units | 15.8K | 15 Aug 2025 | Common Stock | 15.8K | Direct | F1, F5 | ||||||
| holding | TECH | Stock Option (Right to Buy) | 21.3K | 15 Aug 2025 | Common Stock | 21.3K | $74.91 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. |
| F2 | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F3 | 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026. |
| F4 | Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028. |
| F5 | Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F6 | 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027. |
| F7 | Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. |
| F8 | Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F9 | 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028. |
| F10 | Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028. |